Literature DB >> 26095908

Gaseous mediators in resolution of inflammation.

John L Wallace1, Angela Ianaro2, Kyle L Flannigan3, Giuseppe Cirino2.   

Abstract

There are numerous gaseous substances that can act as signaling molecules, but the best characterized of these are nitric oxide, hydrogen sulfide and carbon monoxide. Each has been shown to play important roles in many physiological and pathophysiological processes. This article is focused on the effects of these gasotransmitters in the context of inflammation. There is considerable overlap in the actions of nitric oxide, hydrogen sulfide and carbon monoxide with respect to inflammation, and these mediators appear to act primarily as anti-inflammatory substances, promoting resolution of inflammatory processes. They also have protective and pro-healing effects in some tissues, such as the gastrointestinal tract and lung. Over the past two decades, significant progress has been made in the development of novel anti-inflammatory and cytoprotective drugs that release of one or more of these gaseous mediators.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Carbon monoxide; Cytoprotection; Hydrogen sulfide; Nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 26095908     DOI: 10.1016/j.smim.2015.05.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  28 in total

Review 1.  Hydrogen sulphide as a signalling molecule regulating physiopathological processes in gastrointestinal motility.

Authors:  M Jimenez; V Gil; M Martinez-Cutillas; N Mañé; D Gallego
Journal:  Br J Pharmacol       Date:  2017-07-27       Impact factor: 8.739

Review 2.  2016 Russell Ross Memorial Lecture in Vascular Biology: Molecular-Cellular Mechanisms in the Progression of Atherosclerosis.

Authors:  Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-12-15       Impact factor: 8.311

Review 3.  Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.

Authors:  Gabrielle Fredman; Ira Tabas
Journal:  Am J Pathol       Date:  2017-06       Impact factor: 4.307

4.  D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase.

Authors:  Vincenzo Brancaleone; Iolanda Esposito; Antonella Gargiulo; Valentina Vellecco; Antonia Asimakopoulou; Valentina Citi; Vincenzo Calderone; Thomas Gobbetti; Mauro Perretti; Andreas Papapetropoulos; Mariarosaria Bucci; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2016-03-23       Impact factor: 8.739

Review 5.  Specialized pro-resolving mediators in cardiovascular diseases.

Authors:  Gabrielle Fredman; Matthew Spite
Journal:  Mol Aspects Med       Date:  2017-02-28

Review 6.  Immune resolution mechanisms in inflammatory arthritis.

Authors:  Mauro Perretti; Dianne Cooper; Jesmond Dalli; Lucy V Norling
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

7.  MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.

Authors:  Bishuang Cai; Edward B Thorp; Amanda C Doran; Manikandan Subramanian; Brian E Sansbury; Chyuan-Sheng Lin; Matthew Spite; Gabrielle Fredman; Ira Tabas
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-19       Impact factor: 11.205

Review 8.  Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology.

Authors:  Brian E Sansbury; Matthew Spite
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 9.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 10.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.